𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cochrane review: Inhaled nitric oxide for respiratory failure in preterm infants

✍ Scribed by Keith J Barrington; Neil Finer


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
344 KB
Volume
5
Category
Article
ISSN
1557-6272

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cochrane review: Nitric oxide for respir
✍ Dr NN Finer; KJ Barrington πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 466 KB

## Abstract ## Background Nitric oxide is a major endogenous regulator of vascular tone. Inhaled nitric oxide gas has been investigated as a treatment for persistent pulmonary hypertension of the newborn. ## Objectives To determine whether treatment of hypoxaemic term and near‐term newborn infan

Response of premature infants with sever
✍ K. P. Van Meurs; W. D. Rhine; J. M. Asselin; D. J. Durand πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 39 KB

Elevated pulmonary vascular resistance is seen in premature infants with severe respiratory distress syndrome (RDS). Inhaled nitric oxide (NO) has been shown to decrease pulmonary vascular resistance and to improve oxygenation in some patients with respiratory failure. The purpose of this study was

Cochrane review: Extracorporeal membrane
✍ Miranda Mugford; Diana Elbourne; David Field πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 366 KB

## Abstract ## Background Neonatal extracorporeal membrane oxygenation (ECMO) is a complex procedure of life support used in severe but potentially reversible respiratory failure in term infants. Although the number of babies eligible for ECMO is small and the use of ECMO invasive and potentially